IRONWOOD PHARMACEUTICALS INC financial data

Symbol
IRWD on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118% % -39%
Return On Equity -9.5% % -1357%
Return On Assets 6.6% % 2838%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 163,058,316 shares
Common Stock, Shares, Outstanding 163,058,316 shares 1.8%
Entity Public Float $102,692,312 USD -89%
Common Stock, Value, Issued $163,000 USD 1.9%
Weighted Average Number of Shares Outstanding, Basic 161,842,000 shares 1.7%
Weighted Average Number of Shares Outstanding, Diluted 162,983,000 shares 1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $296,151,000 USD -16%
Research and Development Expense $95,136,000 USD -15%
Costs and Expenses $197,649,000 USD -23%
Operating Income (Loss) $98,502,000 USD 5.8%
Nonoperating Income (Expense) $28,477,000 USD -2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $70,025,000 USD 7.4%
Income Tax Expense (Benefit) $46,008,000 USD -28%
Net Income (Loss) Attributable to Parent $24,017,000 USD 2629%
Earnings Per Share, Basic 0.16 USD/shares -200%
Earnings Per Share, Diluted 0.13 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $215,456,000 USD 143%
Accounts Receivable, after Allowance for Credit Loss, Current $46,745,000 USD -43%
Assets, Current $274,178,000 USD 50%
Deferred Income Tax Assets, Net $103,433,000 USD -28%
Property, Plant and Equipment, Net $3,408,000 USD -24%
Operating Lease, Right-of-Use Asset $9,340,000 USD -15%
Other Assets, Noncurrent $4,502,000 USD -24%
Assets $396,901,000 USD 13%
Accounts Payable, Current $2,898,000 USD 36%
Employee-related Liabilities, Current $11,590,000 USD -20%
Contract with Customer, Liability, Current $1,107,000 USD -46%
Liabilities, Current $242,218,000 USD 524%
Operating Lease, Liability, Noncurrent $9,870,000 USD -20%
Other Liabilities, Noncurrent $21,648,000 USD 27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,060,000 USD -215%
Retained Earnings (Accumulated Deficit) $1,673,718,000 USD 1.4%
Stockholders' Equity Attributable to Parent $261,835,000 USD 13%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $264,157,000 USD 15%
Liabilities and Equity $396,901,000 USD 13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,954,000 USD -56%
Net Cash Provided by (Used in) Financing Activities $15,555,000 USD -491%
Net Cash Provided by (Used in) Investing Activities $31,000 USD 54%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 163,058,316 shares 1.8%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,922,000 USD -32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $215,456,000 USD 143%
Deferred Tax Assets, Valuation Allowance $126,307,000 USD 19%
Deferred Tax Assets, Gross $232,749,000 USD -8.4%
Operating Lease, Liability $13,122,000 USD -15%
Depreciation $479,000 USD -6.6%
Payments to Acquire Property, Plant, and Equipment $31,000 USD -54%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $22,034,000 USD 356%
Lessee, Operating Lease, Liability, to be Paid $14,854,000 USD -18%
Property, Plant and Equipment, Gross $11,413,000 USD -11%
Operating Lease, Liability, Current $3,252,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,317,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,252,000 USD 2%
Operating Lease, Weighted Average Discount Rate, Percent 0.058 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,732,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,384,000 USD 2%
Deferred Tax Assets, Operating Loss Carryforwards $155,036,000 USD 5.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 75,000,000 shares 0%
Unrecognized Tax Benefits $11,851,000 USD 2.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,451,000 USD 2%
Operating Lease, Payments $788,000 USD 1.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $17,250,000 USD -42%
Interest Expense $27,333,000 USD 303%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%